EmilyYChuMD

Dermatopathology

Associate Professor, Dermatology, Perelman School of Medicine

Dr. Chu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd.
1-330s Perelman Center
Philadelphia, PA 19104
Phone+1 215-662-2737

Fax+1 215-615-3424

University of Pennsylvania Health SystemFellowship, Dermatopathology, 2011 - 2012
University of Pennsylvania Health SystemResidency, Dermatology, 2007 - 2010
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2006 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2006

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FAAD) American Academy of Dermatology

PubMed

Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision.
Jaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, Bryan T Carroll, Caroline Choi Kim
Journal of the American Academy of Dermatology. 2025-01-17
Impact of 8th edition American Joint Committee on Cancer staging changes on sentinel lymph node biopsy practices in melanoma.
Gabriella N Tortorello, Neha Shafique, Anushka Dheer, Emily Y Chu, Michael E Ming
Journal of the American Academy of Dermatology. 2024-11-14
ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology.
Cory L Simpson, Afua Tiwaa, Shivam A Zaver, Christopher J Johnson, Emily Y Chu
JCI Insight. 2024-11-08

Journal Articles

Prognostic Gene Expression Profiling in Cutaneous Melanoma
Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
Evaluation of the Merits and Limitations of Evidence-Based Medicine
Emily Y Chu, Jennifer A Stein, JAMA Dermatology
An Intrapatient Concordance Study of Mismatch Repair Protein Immunohistochemical Staining Patterns in Patients with Muir-Torre Syndrome
Kevin J Gaddis, Emily Y Chu, JAMA Dermatology
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but with Positive Histologic Margins
Douglas Grossman, Vijay Balakrishnan, Laura K Ferris, Geoffrey Lim, Suephy C Chen, Meera Brahmbhatt, Susan M Swetter, Emily Y Chu, Nathaniel Fleming, Caroline C Kim, M..., JAMA
Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy
Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA
Join now to see all

Lectures

Journal Watching
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Evaluation of the Merits and Limitations of Evidence-Based MedicineJune 2020
An Intrapatient Concordance Study of Mismatch Repair Protein Immunohistochemical Staining Patterns in Patients with Muir-Torre SyndromeApril 2020
Join now to see all

Reviewers' List December 2020August 12th, 2020
Reviewers' List December 2019August 23rd, 2019
'DWTS' Star Witney Carson's Foot Discoloration Turned Out to Be MelanomaAugust 24th, 2018
Join now to see all